Science in Seattle

Chiari Malformation Webinar
2021-02-03 17:00 - 20:00 (America/Vancouver) | Online
Live webinar with physicians about Chiari Malformation

GU Oncology Seminar Series
2021-02-04 17:00 - 18:00
The Genitourinary (GU) Oncology Seminar Series offers a weekly seminar featuring lectures by Fred Hutch, UW, and external scientists to share their latest developments and recent research. This series is hosted jointly by the PNW Prostate SPORE, Program in Prostate Cancer Research (PPCR), and Bladder Cancer Group (BCG).
Livestream: https://us02web.zoom.us/j/85023704247
Feedback form for speaker: https://ppcrspore.formstack.com/forms/ppcr_feedback
View past seminar recordings

Date:
Thursday, February 04, 2021

Start Time:
5 p.m. PST

Host or Sponsor:
Pacific Northwest Prostate Cancer SPORE

Location:
Virtual

Speaker or Presenter:
John Gore, MD, MS, FACS

Contact Information:
PPCR_SPOREadmin@fredhutch.org

Transplantation & Cellular Therapy
2021-02-08 08:00 - 2021-02-12 17:00
Follow Fred Hutch at TCT: #TCTM21

Fred Hutch scientists are presenting new research findings at the Transplantation & Cellular Therapy (TCT) Meetings. The TCT represents the combined annual meetings of the American Society for Blood and Marrow Transplantation (ASBMT) and the Center for International Blood & Marrow Transplant Research (CIBMTR).
The meeting features the E. Donnall Thomas Lecture, named after the late Nobel laureate who pioneered bone marrow transplantation at Fred Hutch. The honor recognizes an eminent physician or scientist who has contributed meritoriously to the advancement of knowledge in blood and marrow transplantation.
Fred Hutch and Seattle Cancer Care Alliance will co-host a virtual booth at the meeting.

CFAR Seminar- The AMP Trials
2021-02-11 16:00 - 17:00
Start Date and Time
February 11, 2021 – 4:00pm

End Date and Time
February 11, 2021 – 5:00pm

Speaker: Lawrence Corey, MD
Past President and Director, Fred Hutch
Professor, Vaccine and Infectious Disease Division, Fred Hutch
Professor, Medicine and Laboratory Medicine, UW
Zoom – washington.zoom.us/j/91567478853
Dr. Lawrence Corey will review the efficacy data from the Antibody Mediated Prevention (AMP) trials conducted by the HIV Vaccine Trials Network (HVTN) and the HIV Prevention Trials Network (HPTN)

Dr. Larry Corey is an internationally renowned expert in virology, immunology and vaccine development, and the former president and director of the Fred Hutchinson Cancer Research Center. His research focuses on herpes viruses, HIV, the novel coronavirus and other viral infections, including those associated with cancer. He is principal investigator of the HIV Vaccine Trials Network, or HVTN, which conducts studies of HIV vaccines at over 80 clinical trials sites in 16 countries on five continents. Under his leadership, the HVTN has become the model for global, collaborative research. Dr. Corey is also the principal investigator of the Fred Hutch-based operations center of the COVID-19 Prevention Network (CoVPN) and co-leads the Network’s COVID-19 vaccine testing pipeline. The CoVPN is carrying out the large Operation Warp Speed portfolio of COVID-19 vaccines and monoclonal antibodies intended to protect people from COVID-19.
Dr. Corey is a member of the US National Academy of Medicine and the American Academy of Arts and Sciences, and was the recipient of the Parran Award for his work in HSV-2, the American Society of Microbiology Cubist Award for his work on antivirals, and the University of Michigan Medical School Distinguished Alumnus Award. He is one of the most highly cited biomedical researchers in the last 20 years and is the author, coauthor or editor of over 1000 scientific publications.

Biostatistics Seminar Series
2021-02-17 12:00 - 13:00
The Fred Hutch Biostatistics Program hosts seminars featuring presentations by Hutch and outside scientists to share their latest developments and recent research. Each seminar includes an hour-long presentation and discussion during which speakers showcase their work and findings.
This seminar will be held on Zoom due to the COVID-19 pandemic.
Lung cancer is one of the most common cancers worldwide and the leading cause of cancer deaths both globally and in the United States. The National Lung Cancer Screening Trial showed annual screening by low-dose computed tomography (LDCT) reduced mortality and in 2013 the US Preventative Services Task Force recommended screening by LDCT for high-risk smokers. A predictive model for 6-year risk of lung cancer was developed using results of the Prostate, Lung, Colon, and Ovarian Cancer Screening Trial (PLCOm2012) and put forth as selection criteria for referral to screening. The Hanash Lab at MD Anderson has established and validated a panel of four circulating protein biomarkers (4MP) for lung cancer risk assessment. In this talk, I will describe joint work with Ziding Feng and the Hanash lab leading to a definitive validation of the 4MP using preclinical specimens from the PLCO biorepository, highlight validation of selection criteria based on combining the 4MP with PLCOm2012, and discuss next steps for investigating the clinical utility of a biomarker-based strategy for referral to LDCT screening.

Global Oncology Lecture Series
2021-02-22 08:00 - 09:00
The Global Oncology (GO) Lecture Series Webinar features presentations with unique perspectives. The goal of the webinar series is to bring together those working in the global cancer field to share research or program updates and establish closer working collaborations. Each webinar includes an hour-long presentation and discussion during which speakers showcase their work and findings. The series allows Fred Hutch faculty, employees, Consortium members, students, and global cancer or global health community members to be a part of this important conversation.
Henry Ddungu, MBChB, MMed, Hematology Consultant, Uganda Cancer Institute
PRESENTING: Optimal Use of Platelet Transfusion in Cancer (OPTIC) in sub-Saharan Africa
Dr. Ddungu began his Ph.D. studies in Seattle with coursework at the University of Washington and clinical oncology rotations at Seattle Cancer Care Alliance and Harborview Medical Center. Since returning to Kampala in 2012, he has continued his doctoral research at Makerere University, studying the optimal use of platelet transfusion for oncology patients at the UCI. He is currently a hematologist and director of laboratory operations at the UCI.

Progress on the Pandemic: A Year of Tackling COVID-19
2021-02-23 09:00 - 10:30
Fred Hutch is at the center of a nonstop scientific sprint to understand and stop the coronavirus. Join us Tuesday, February 23, for Science Says, our monthly researcher roundtable, to meet scientists who are leading vaccine trials, guiding public health policy, tracking genetic changes to the virus, and studying new treatments for COVID-19.
Please RSVP by Monday, February 22. After you register, you will receive instructions for how to join the conversation by computer, tablet, or phone.

Speakers

Dr. Thomas J. Lynch Jr.

Dr. Thomas J. Lynch Jr., who will lead the conversation, is Fred Hutch president and holder of the Raisbeck Endowed Chair. He is a lung cancer physician and scientist who is respected worldwide for his pioneering role in precision medicine and his leadership in academic medicine and industry. He joined Fred Hutch one year ago — just weeks before COVID-19 shutdowns began — and has guided the organization’s response to the pandemic with urgency, compassion, and a commitment to sparking scientific solutions.

Dr. Michele Andrasik

Dr. Michele Andrasik is one of the directors of the COVID-19 Prevention Network (CoVPN), which is conducting Phase 3 efficacy trials for vaccines as part of Operation Warp Speed. She has worked to ensure that communities hit hardest by COVID-19 are adequately represented in vaccine trials, and she helps create educational materials to increase understanding and uptake of approved vaccines.

Dr. Trevor Bedford

Dr. Trevor Bedford is a computational biologist who has been at the forefront of tracking the virus that causes COVID-19 since it emerged. His expertise and insight, along with the software tool he co-developed, Nextstrain, have been instrumental to understanding the rapid spread and evolution of the coronavirus — and have earned him nearly 300,000 followers on Twitter.

Dr. Larry Corey

Dr. Larry Corey is a world-renowned virologist, principal investigator of the HIV Vaccine Trials Network, and Fred Hutch president and director emeritus. As head of the COVID-19 Prevention Network operations center, located at Fred Hutch, and co-leader of the network’s massive clinical trials program, he plays a critical role in Operation Warp Speed, the nation’s monumental effort to develop, test, and distribute vaccines in record time.

Dr. Josh Schiffer

Dr. Josh Schiffer is an infectious disease physician who uses computer modeling to study COVID-19 transmission and super-spreading. His research has reinforced the importance of widespread masking and testing, and he is a strong advocate for developing treatments that interrupt COVID-19 early in the course of infection. Dr. Schiffer is one of many researchers leading clinical trials at Fred Hutch’s new COVID-19 Clinical Research Center.

Open for (Neuro)Science Tutorials: New from the Allen Cell Types Database
2021-02-24 10:00 - 11:00
Open for (neuro)science tutorials: New from the Allen Cell Types Database

Date:
Wednesday, February 24, 2021
Time:
10:00 AM – 11:00 AM
Location:

Virtual

Join us at this tutorial to learn about new work from the Allen Cell Types Database, including patch-seq and synaptic physiology data. Learn how and why to use these open resources to support and accelerate your research.

Creating a Successful Academic Spin-Out
2021-02-26 10:00 - 11:30
Live, 90-minute event featuring 3 distinguished academics / entrepreneurs discussing their Academic Spin-Out successes, adventures and insights.
Bill Walker describes launching four companies from within academia and from coaching dozens of academic startups. He will share the general principles he’s identified and some of the ways that academic ventures go off the rails.
Lori Arakaki shares insights and lessons from her just closed $4.6 Million in funding to develop the first cell O2 monitor for reducing organ failure as she describes Opticyte’s journey so far.
Dr. Magdy Younes draws upon his experience as a Canadian physician and researcher specializing in respirology and sleep medicine to share how an academic physician ended up being an inventor/entrepreneur? Spoiler alert: “It is not what you think”.
Each presenter will include plenty of examples and actionable advice.
“Fantastic presenters and very informative. Thank you.” -Attendee Feedback from previous Virtual Medical Device Playbook events.
#MDPLAYBOOK
TOPICS:
Behaviors and decisions that seem to be almost universally fatal for Academic Spin-Outs
How do I know if I have a good idea? • Should I leave my day job? • How can I find a “good” CEO to run my venture? • Where do I go to raise money?
Raising capital, grant strategies, relationship with university
Unique struggles that co-founders who are academics can face and need to overcome

Webinar Series: The Microbiome and Different Diets
2021-03-02 17:00 - 18:00
WHEN
Tuesday, Mar 2, 2021, 5 – 6 p.m.

Monthly on the 1st Tuesday of the month starting March 2, 2021 through July 6, 2021

DESCRIPTION

Join William DePaolo, PhD, immunologist and intestinal microbiome specialist, Division of Gastroenterology, UW Medicine, for a five part seminar series on the microbiome. All seminars will be via Zoom at 5:00 PM (PT) on the first Tuesday of the month. This is a free series and you are welcome to attend all or just one but, you must register to receive the Zoom link and passcode.
*Please note that a new Zoom passcode will be sent out prior to each talk.*
March 2 – Different diets
April 6 – Lifestyle
May 4 – COVID19
June 1 – Antibiotics
July 6 – Over-the-counter-drugs & probiotics
Register for one or all talks, here.
Questions? Email Amy Parker, ‘Parker,’ at aparker@medicine.washington.edu
PDF flyer

EVENT TYPES
Lectures/Seminars

EVENT SPONSORS
